Allianz Asset Management
ACAD icon

Allianz Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$369K Sell
17,100
-16,500
-49% -$356K ﹤0.01% 1438
2025
Q1
$558K Sell
33,600
-5,000
-13% -$83.1K ﹤0.01% 1389
2024
Q4
$708K Buy
38,600
+10,600
+38% +$195K ﹤0.01% 1323
2024
Q3
$431K Buy
+28,000
New +$431K ﹤0.01% 1448
2024
Q1
Sell
-6,400
Closed -$200K 1640
2023
Q4
$200K Buy
+6,400
New +$200K ﹤0.01% 1570
2022
Q3
Sell
-48,205
Closed -$679K 1434
2022
Q2
$679K Buy
48,205
+13,105
+37% +$185K ﹤0.01% 1595
2022
Q1
$850K Hold
35,100
﹤0.01% 1615
2021
Q4
$820K Buy
+35,100
New +$820K ﹤0.01% 1661
2021
Q2
Sell
-107,185
Closed -$2.77M 1891
2021
Q1
$2.77M Sell
107,185
-138,388
-56% -$3.57M ﹤0.01% 1170
2020
Q4
$13.1M Sell
245,573
-143,804
-37% -$7.69M 0.01% 739
2020
Q3
$16.1M Sell
389,377
-26,245
-6% -$1.08M 0.02% 617
2020
Q2
$20.1M Buy
415,622
+136,895
+49% +$6.64M 0.02% 553
2020
Q1
$11.8M Buy
278,727
+58,760
+27% +$2.48M 0.02% 681
2019
Q4
$9.41M Buy
219,967
+163,138
+287% +$6.98M 0.01% 951
2019
Q3
$2.06M Sell
56,829
-4
-0% -$145 ﹤0.01% 1438
2019
Q2
$1.52M Sell
56,833
-4,361
-7% -$117K ﹤0.01% 1632
2019
Q1
$1.64M Buy
61,194
+6,927
+13% +$186K ﹤0.01% 1607
2018
Q4
$870K Buy
+54,267
New +$870K ﹤0.01% 1717
2018
Q2
Sell
-27,905
Closed -$627K 2084
2018
Q1
$627K Hold
27,905
﹤0.01% 1831
2017
Q4
$840K Sell
27,905
-1,148
-4% -$34.6K ﹤0.01% 1779
2017
Q3
$1.1M Sell
29,053
-85
-0.3% -$3.2K ﹤0.01% 1682
2017
Q2
$835K Sell
29,138
-36,195
-55% -$1.04M ﹤0.01% 1741
2017
Q1
$2.24M Buy
65,333
+5,345
+9% +$183K ﹤0.01% 1452
2016
Q4
$1.73M Sell
59,988
-6,204
-9% -$179K ﹤0.01% 1523
2016
Q3
$2.16M Sell
66,192
-65,754
-50% -$2.14M ﹤0.01% 1461
2016
Q2
$4.28M Buy
131,946
+51,196
+63% +$1.66M ﹤0.01% 1190
2016
Q1
$2.26M Buy
80,750
+4,950
+7% +$138K ﹤0.01% 1359
2015
Q4
$2.71M Hold
75,800
﹤0.01% 1294
2015
Q3
$2.51M Hold
75,800
﹤0.01% 1266
2015
Q2
$3.17M Buy
+75,800
New +$3.17M ﹤0.01% 1232